Redefining Clinical Trials: The Age of Personalized Medicine Gayathri Vaidyanathan Cell Volume 148, Issue 6, Pages 1079-1080 (March 2012) DOI: 10.1016/j.cell.2012.02.041 Copyright © 2012 Elsevier Inc. Terms and Conditions
Figure 1 Attrition Rate of Late-Stage Drug Development Data for phase II from 2008-2010 and Phase III from 2007-2010. Adapted from Arrowsmith, 2011, Nat. Rev. Drug Discov. 10, 87. Cell 2012 148, 1079-1080DOI: (10.1016/j.cell.2012.02.041) Copyright © 2012 Elsevier Inc. Terms and Conditions